WDR40C Inhibitors
WDR40C inhibitors encompass a diverse set of chemical compounds that exert their effects through various biochemical mechanisms, ultimately leading to the inhibition of WDR40C function. For example, certain kinase inhibitors target cell cycle regulatory kinases, effectively impeding cell cycle progression and indirectly inhibiting WDR40C activity, which is implicated in cell cycle control. Other compounds act by modulating chromatin structure and gene expression, which can result in the decreased expression of WDR40C by altering the transcriptional environment of its gene. This group includes inhibitors that target the epigenetic regulation of gene expression, such as histone deacetylases, leading to changes in chromatin accessibility and, consequently, gene expression profiles that may include WDR40C.
In addition to these, some inhibitors interfere with major signaling pathways associated with cell growth, proliferation, and survival, which may involve WDR40C function. Compounds that inhibit the PI3K/AKT/mTOR pathway, for instance, can negatively affect cell growth and proliferation, potentially reducing the activity of WDR40C if it is part of this pathway. Similarly, proteasome inhibitors can disrupt protein homeostasis within the cell, which may lead to a decrease in WDR40C activity if it is associated with proteins targeted for proteasomal degradation. Other inhibitors target stress response pathways or modulate the cellular environment by affecting processes such as immune response and angiogenesis, which could indirectly lead to the inhibition of WDR40C if it is implicated in these processes.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Palbociclib | 571190-30-2 | sc-507366 | 50 mg | $321.00 | ||
A cyclin-dependent kinase inhibitor that disrupts cell cycle progression by inhibiting CDK4/6, leading to the indirect inhibition of WDR40C involved in cell cycle regulation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Histone deacetylase inhibitor that alters chromatin structure and gene expression, potentially decreasing the expression of WDR40C by affecting its gene transcription environment. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
PI3K inhibitor that blocks the PI3K/AKT/mTOR signaling pathway, which can indirectly inhibit WDR40C if WDR40C is involved in this pathway by affecting downstream effects on cell growth and proliferation. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can lead to the inhibition of downstream proteins involved in cell growth and proliferation, potentially including WDR40C if WDR40C function is mTOR-dependent. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
MEK inhibitor that impairs the MAPK/ERK pathway, which is crucial for cell proliferation and survival, thus indirectly inhibiting WDR40C if it plays a role in this signaling pathway. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that impedes cytokine production and cell differentiation, potentially inhibiting WDR40C if it is implicated in stress response pathways mediated by p38 MAPK. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that leads to the buildup of proteins targeted for degradation, which could inhibit WDR40C indirectly by disrupting proteostasis and cell cycle control if WDR40C is implicated. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Can indirectly inhibit WDR40C by altering the cellular environment and possibly affecting WDR40C-related pathways involved in cell growth. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that prevents the activation of ERK1/2, potentially inhibiting WDR40C activity indirectly if WDR40C is associated with the MAPK/ERK signaling pathway. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
MDM2 antagonist that stabilizes p53, leading to cell cycle arrest and apoptosis, potentially inhibiting WDR40C indirectly if WDR40C is involved in p53-regulated pathways. | ||||||